Main > IMMUNOLOGY > USA. G. GCA>Treat.>TocilizuMAb

---

USA. G. GCA>Treat.>TocilizuMAb's subsections
(*) USA Approval Date: 2017. 05.22
Company
GCA: Giant Cell Arteritis
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2017. 05.23
TradeMark
TradeMark Web-Site

USA. G. GCA>Treat.>TocilizuMAb's products
This section has no products